This episode features an interview with Christian Howell, Chief Commercial Officer at Cognito Therapeutics, a biotech company pioneering a neurotechnology approach to treat Alzheimer's disease. Christian draws on his diverse background spanning the military, medical device giant Medtronic, and now the biotech industry.
The conversation covers Cognito's evidence generation strategy to demonstrate the value of their non-invasive neural stimulation therapy. As Christian states, "It's critical to bring all the key players to the table early and be fully transparent about your data - that's how you build trust and alignment around value."
Key takeaways include:
- The importance of cross-sector partnerships and stakeholder engagement from day one
- Fostering a culture of innovation through mission-driven leadership
- Promoting employee accountability to take smart risks
- Learning quickly from failures versus avoiding them
With experience implementing value-based healthcare models at Medtronic, Christian also shares unique perspectives on driving innovation while developing novel therapies.
Learn from Christian’s approach spanning evidence generation, collaborative value demonstration, and creating an environment primed for breakthrough thinking. Listen in and get inspired!
Are you leading a biotech and would like to share your experience with our podcast audience? We'd love to hear from you! Please reach out to us.
What is The Emerging Biotech Leader?
Biotech—it's complicated.
A successful product launch requires grit, determination, and clear direction.
But let’s be real, the path to launch isn’t a straight one.
There are curves, hard turns, and dead ends.
Here’s the good news, you don’t have to navigate the complexities alone.
Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.